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Abstract
Unlike other countries in South Asia, in Nepal research in the health sec-
tor has a relatively recent history. Most health research activities in the
country are sponsored by international collaborative assemblages of aid
agencies and universities. Data from Nepal Health Research Council
shows that, officially, 1,212 health research activities have been carried
out between 1991 and 2014. These range from addressing immediate
health problems at the country level through operational research, to eval-
uations and programmatic interventions that are aimed at generating evi-
dence, to more systematic research activities that inform global scientific
and policy debates. Established in 1991, the Ethical Review Board of the
Nepal Health Research Council (NHRC) is the central body that has the
formal regulating authority of all the health research activities in country,
granted through an act of parliament. Based on research conducted
between 2010 and 2013, and a workshop on research ethics that the
authors conducted in July 2012 in Nepal as a part of the on-going
research, this article highlights the emerging regulatory and ethical fields
in this low-income country that has witnessed these increased health
research activities. Issues arising reflect this particular political economy
of research (what constitutes health research, where resources come
from, who defines the research agenda, culture of contract research,
costs of review, developing Nepal’s research capacity, through to the poli-
tics of publication of data/findings) and includes questions to emerging
regulatory and ethical frameworks.
INTRODUCTION
There is much recent debate around health sector research
on the relationship between types of research, the nature of
evidence generated, and their suitability for informing pol-
icy1 and to the limits of systematic reviews in the complex
context of health interventions in low-income countries.2
Much of the scholarship focusing on health sector research
in low-income countries has focused on pharmaceutical
development and direct research on human subjects within
the field of clinical trials and health experimentation.3
Existing debate on health research ethics tends to empha-
sise informed consent at the expense of the broader aspects
of our ethical responsibilities.4
Although there has been increasing research activity
around health service research and operational research in
low and middle-income countries, much less work has
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been done to discuss ethical dimensions of this field.5 The
application of protocols and techniques for research into
human subjects is now increasingly criticized as inappro-
priate or inadequate for research into more complex health
systems related issues in low-income countries.6 Low-
income countries are heavily dependent on external assis-
tance to support their health systems and service delivery
work. Health sector research, often organized as externally
assisted interventions that generate evidence, plays a key
role in shaping national policies, plans and programmes.
The political economy of research in low-income countries–
including the uneven distribution of resources, external
dependence on funding and limited local capacity–poses
specific challenges to low-income countries that have
emerging regulatory and ethical frameworks.
Drawing on findings from our “Biomedical and Health
Experimentation in South Asia” [BHESA] research project
conducted in Nepal between 2010 and 2013, this article dis-
cusses the emerging regulatory and ethical fields, showcas-
ing a low-income country that has seen increased health
research activities that range from health experiments, ran-
domised controlled trials to research activities around health
sector programmatic interventions. We began by mapping
all of the experimental research ongoing in the health sector
in Nepal between 2000 and 2010. The major source for our
mapping was a bibliography prepared by the Nepal Health
Research Council of the research studies that were approved
from 2003 to 2009. In addition to the bibliography, the US
registry (clinicaltrials.gov), Current Controlled Trials, and a
web search of sponsors, research organizations and journal
articles also served as sources of data for our mapping exer-
cise. This provided us with an overview of the nature of
health research activities in the country more broadly and
health experimentation specifically. In addition, as a compo-
nent of broader ethnographic research, we carried out 73
key interviews with investigators, managers and regulators
soliciting their experiences and perceptions on the practice
of research, the general health research environment and
emerging ethical issues in the country.
One of the key themes that emerged during our research
related to whether the research designed around program-
matic interventions–such as feasibility studies, service deliv-
ery research, assessments and evaluations that are not seen
as “health research experiments”– should be counted
broadly as “health research” at all. To explore this further,
and as part of the iterative nature of our research, we con-
vened and conducted a workshop to look into the issues
around the conduct of ethical review of research in the
health sector in the context of Nepal. The main objective of
the workshop was to bring together investigators and
research managers from key institutions (academic, NGOs,
government and private sector) involved in conducting
health research to promote a dialogue on the current state of
formal ethical review and practice in country. In short, the
workshop offered an opportunity to discuss and debate the
experiences and challenges regarding ethical process in the
conduct of experimental research studies.7 This article dis-
cusses issues arising that reflect a particular political econ-
omy of research - where funding comes from, who defines
the research agenda, the costs of review, developing Nepal’s
research capacity, through to the politics of publication of
research findings - and includes questions relevant to emerg-
ing regulatory and ethical frameworks.
POLITICAL ECONOMY OF HEALTH
SECTOR RESEARCH IN NEPAL
Unlike other countries in South Asia, in Nepal scientific
research has a relatively recent history.8 Health research in
Nepal has its origin in aid from the United States started in
1951. In its mission to support Nepal’s development, one of
the first challenges USOM (United States Operations Mis-
sion, later renamed as USAID) faced was the lack of data. A
USOM document published in 1958 stated: “Reliable health
statistics do not exist. This makes the assessment of health
conditions and their exact nature and scope very difficult to
relate to the specific problem of resource development and
utilization”9. USOM undertook Nepal’s first systematic
research activity, a survey on malaria, in 1952, designed
within the context of the country’s Malaria control interven-
tions. The first Nepal Health Survey was carried out in
1965-66 with the support of the University of Hawaii and
the Thomas A. Dooley Foundation. It had a budget of
250,000 USD. Its main objective was to supply baseline
quantitative data to assist the Ministry of Health in planning
and to be useful in measuring future progress of health work
in Nepal.10 In its early days, “To improve project design and
implementation, USAID increasingly relied on sector assess-
ments, pilot studies, and the hands-on field presence of
Peace Corps Volunteers (PVCs).”11 The health development
© 2016 The Authors Developing World Bioethics Published by John Wiley & Sons Ltd
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14: 28-37.
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8 Dr Carl E. Taylor from the Chicago Natural History Museum expedition
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9 J. M. Isaacson et. al. 2001. Half-a-Century of Development: The History
of U.S. Assistance to Nepal, 1951-2001. Kathmandu, Nepal. USAID: 43.
10 R. M. Worth & N. K. Shah. 1969. Nepal Health Survey, 1965-1966.
Honolulu, University of Hawaii Press.
11 Isaacson et. al., op. cit. note 9, p. 90.
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anthropologist Justice, writing of the 1970s, suggested “gov-
ernment and donor agencies produce many kinds of reports,
often voluminous: background papers, feasibility studies,
annual reports, progress evaluation and project proposals.”12
Over the last 60 years, health related research conducted
in Nepal has been varied. It ranges across more pure
biomedical research, into arenas where evidence is being
generated for programmatic interventions into the health
field more generally. This generation of evidence around
programmatic interventions has been sustained by assem-
blages of local and international organizations and universi-
ties, and supported and funded by aid institutions.13 These
assemblages and institutional forms are not only critical in
the generation of evidence but also provide much-needed
networks of support for the successful up scaling of pilot
projects. It is, however, impossible to trace all the research
activities in Nepal, especially those that are designed to gen-
erate evidence around programmatic interventions. This is
mainly because not all research activities are registered with
Nepal Health Research Council (NHRC), there is no stan-
dard database and no clear definition as to what is regarded
as health research. Without knowing how many and what
research activities are taking place in the health sector, how-
ever defined, NHRC faces a major challenge in the regula-
tion of research activities. There are, however, several
examples of interventions that are at the interface of health
research and programmatic intervention in Nepal. Here we
consider the following as illustrations of these forms.
From 1988-90, USAID funded the Nepal Nutrition Inter-
vention Project-Sarlahi (NNIPS) on Vitamin A capsule dis-
tribution in Sarlahi district, which was implemented by
Johns Hopkins University in collaboration with the National
Society for the Prevention of Blindness, Kathmandu. The
project carried out a randomised, double-masked, placebo-
controlled community trial of 28,630 children aged 6-72
months in rural Nepal. The study results showed 30% reduc-
tion in infant mortality.14 Results from this study and
another study funded by USAID on Vitamin A15 were
instrumental in the government of Nepal introducing the
National Vitamin A Program in Nepal.16 Likewise, another
USAID funded ARI Intervention Trial in Jumla district was
implemented by John Snow Inc. in collaboration with the
Ministry of Health. This demonstrated that community
health workers, with limited training, could reliably manage
childhood pneumonia, a major cause of deaths in children
under five years old.17 The positive results led the Govern-
ment of Nepal–with support–to introduce a community-
based component within the national ARI control pro-
gramme, and to further mobilise Female Community Health
Volunteers (FCHVs) to administer antibiotics. A technical
working group that consisted of the government staff, UNI-
CEF, WHO, USAID and John Snow Inc. was established in
1993 to take the programme further.18
Do such programmes constitute health research in the
biomedical sense, or are they more broadly development
interventions? What are the broader ethical issues involved
in such research activities when they are embedded within
such development interventions?
A mapping exercise on health research experiments we
conducted in 2011-2012 showed that there were 162 studies
undertaken in Nepal between 2000 and 2010; many other
studies were undertaken in this period that did not fit the cri-
teria of health experiments.19 The number of Principal
Investigators (PIs) in these studies was 132. Of these 69
were Nepali, 63 were foreign, 84 were male and 48 were
female. Among the 132 PIs, 63 were affiliated with universi-
ties and academic institutions, 25 with other health facilities
(hospitals, clinics), 12 with INGOs, 10 with NGOs and 7
with government departments. The affiliation of 15 PIs
could not be identified because the organization details were
not available. A total of 26 sponsors/funders were identified,
ranging from bilateral and multilateral institutions to univer-
sities and private foundations. There were 56 organizations
implementing the 132 studies: 36 were local and 20 were
international. The international research implementing orga-
nizations were mostly universities from the US, Belgium,
Australia, UK, Japan, and Denmark and some INGOs work-
ing in Nepal, such as Care International and Heifer Interna-
tional. The local research organizations were NGOs or
hospitals. With the exception of GlaxoSmithKline, who
sponsored the trial of a Hepatitis E vaccine20, no other phar-
© 2016 The Authors Developing World Bioethics Published by John Wiley & Sons Ltd
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opment in Nepal, Berkeley, University of California Press: 112.
13 I. Harper. 2014. Development and Public Health in the Himalaya:
Reflections on healing in Contemporary Nepal. London and New York.
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and impact/evaluation studies.
20 This trial in Nepal had a controversial history: the Hepatitis E vaccine
trial sponsored by the US Army as a Phase II/III clinical trial came under
sustained criticism. Community and political leaders raised objections con-
cerning the US army’s interest in vaccines for a disease found in Nepal,
and how the trial participants and other local people would benefit from
the research. For details, see: Harper, op cit., note 4.
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maceutical companies funded trials in Nepal. The largest
sector in Nepali health research was maternal and child
health. There were also studies on high altitude medicine,
tuberculosis, abortion, encephalitis, malaria, leprosy,
typhoid and HIV, among others.
Broadly, and inductively, our research teased out the
following issues and themes that were emergent in this
field of health research in Nepal and their ethical implica-
tions.
Firstly, there has been a steady increase in the number
of research activities and this is linked to a number of fac-
tors: the rise in the number of medical schools21 and asso-
ciated research activities, which while increasing in
number, are often poorly supported in terms of an institu-
tional culture of research; and that there has been an
increased demand to generate “evidence” around health
sector programmatic interventions. When compared to
other parts of South Asia22, there is relatively little
biomedical research conducted in Nepal, which is limited
to a few public hospitals such as Patan Hospital, Ananda-
ban Hospital, the Teaching Hospital and a couple of pri-
vate research organizations that have been established in
the last 10 years. Most research activities are organised as
international collaborative assemblages of aid agencies,
universities, contract research organisations, NGOs, local
research firms and individual researchers/investigators.
Second, except for a few medical education institutions,
several NGOs and a few private research firms specializing
in health systems research have emerged in the country
that mainly work on short-term sub-contractual agreements
with the government, bilateral, multilateral and private phi-
lanthropic organisations. The most active local research
institutions include New Era, Valley Research Group, Cen-
tre for Research on Environment Health and Population,
Health Research and Social Development Forum and
Nepal Public Health Foundation. New Era, for example,
was established by three Peace Corps Volunteers in 1971,
and was the first research firm established to work in
Nepal. Although it was initially registered in the United
States, in 1977 it was registered in Nepal and Nepali
researchers took over from the Peace Corps Volunteers.
This institution is the most contracted research firm in
Nepal for quantitative surveys and has worked very closely
with USAID for carrying out the Demographic and Health
Surveys. Given the small number of these institutions in
the country, which reflects the limited research, they are
often oversubscribed by the sponsors. The short-term nat-
ure of the contracts mean that they are constantly busy in
simultaneously handling multiple projects while moving to
the next ones.
Third, a particular culture of contract research, espe-
cially within health systems research, is prevalent. There is
the widespread practice of individual researchers and insti-
tutions working on short-term contracts for sponsors,
mainly INGOs, bilateral and multilateral organisations,
where they work to carry out feasibility studies, evaluation
studies, baseline and end-line surveys. Generally, commis-
sioning sponsors give preliminary research designs and
have short time frames with very little or no protected time
to write for publications. In some cases, they also deter-
mine the sample size and the study sites. In addition to the
design, sponsors are often involved in monitoring as well
as the final publication of the results. Often sponsors with-
held the ownership of the data and sub-contractors may
have limited ownership on the data. The research reports
do not always include the name of the researchers as
authors on the front pages, but they are included in the
acknowledgements section. Although contracts are for-
mally awarded on a competitive basis, “trust” between
sponsors and the contract research organisations is often
rooted in prior working relationships and is the determin-
ing factor in awarding contracts. New Era, for example,
continues to conduct the USAID funded Demographic and
Health Surveys. For the conduct of the research itself, the
types of personal and institutional networks developed dur-
ing the research process are crucial to the formation and
development of the research capacity. In addition, the dis-
semination of findings and the policy domain into which
research was designed to fit is also dependent on these per-
sonalised networks. This is illustrated, for example, in an
operational study on the feasibility of the distribution of
misoprostol (known as matri surakschya chakki in Nepali)
by Female Community Health Volunteers (FCHVs) in
Banke district conducted between 2005-07 under the
USAID funded Nepal Family Health Programme (NFHP).
The NFHP was a consortium led by John Snow Inc with a
number of national and international partners. One of
NFHP’s focus was to tackle post-partum hemorrhage and
prevent maternal deaths in home deliveries in Nepal. Much
resources and energy were expended into facilitating gov-
ernment involvement in all stages of the programme lead-
ing up to the successful scaling up of the intervention in
national policy in 2010. Interacting, spending time and
engaging with senior government officials through the pro-
gramme structure opened a pathway for influencing gov-
ernment policy.
Fourth, limited locally available research funding means
that local researchers and institutions actively look to
© 2016 The Authors Developing World Bioethics Published by John Wiley & Sons Ltd
21 For details on the rise of private medical institutions and nursing
schools, see: I. Harper. 2011. World Health and Nepal: Producing Interna-
tionals, Healthy Citizenship and the Cosmopolitan. In David Mosse (ed)
Adventures in Aidland: The Anthropology of Professionals in International
Development. Berghahn: 123-138; R. Adhikari. 2008. The Business Nurs-
ing Complex: Understanding Nursing Training in Nepal. Studies in Nepali
History and Society 13; 297-322.
22 B. Simpson et. al. Pharmaceuticalisation and ethical review in South
Asia: Issues of scope and authority for practitioners and policy makers.
Soc Sci Med 2015; 131: 247-254; S. Sariola et. al. Big-pharmaceuticalisa-
tion: Clinical trials and Contract Research Organisations in India. Soc Sci
Med 2015; 131: 239-246.
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engage in research collaborations with Northern research
partners that include international research institutions and
universities. These research partnerships and collaborations
are shaped by the availability of resources and partners,
and the practicalities of carrying out research as well as by
the existence of networks. While there was a widespread
sense that local research institutions and investigators are
now involved as more active research partners, rather than
being treated as ‘sleeping partners or Sherpas’, Northern
partners continue to take the lead in identifying research
problems, crafting research questions and drafting method-
ologies to organise the overall research project. Though
informed and involved in the design of the protocols, lack
of sufficient information on scientific debates means that
the contribution of Nepal based researchers and research
organisations is often limited to providing minimum feed-
back on the protocols.
Fifth, there are continuing issues with the development
of research capacity within Nepal, and institutional capac-
ity to do research related work. One the first issues is the
rapid turnover of staff within these organizations. The
political economy of development work in Nepal has
resulted in a highly stratified pay structure. Individuals
with particular skills (for example, Nepal has a severe
shortage of qualified experienced statisticians) are able to
move across institutional spaces and demand higher wages.
This is particularly so in the Kathmandu valley where most
of these organizations are based and it has resulted in stiff
competition for the employment of staff with the capacity
to undertake both programmatic and research based inter-
ventions. The consequent rapid turnover of staff and vola-
tile pay structure means that institutional capacity is often
flagging. In addition, in the government run institutions
there is overt political interference with staff being
replaced with changes in government, and where research
is being conducted, direct interference with the research
itself, something that the Maoists during the insurgency
were particularly prone to do. The sustained political insta-
bilities are thus a particular issue. This is as evident in the
NHRC, as elsewhere, where, for example, changes in
which party controls the Ministry of Health results in
sweeping changes in the staffing of bureaucracies associ-
ated with the ministry.
Finally, as in other low-income countries, health
research in Nepal is conducted in an arena of structural
inequalities where there is a lack of technology, infrastruc-
ture and funding. Laboratories, for example, do not have
the most up to date equipment. Procuring this is frequently
dependent on grants from external agencies, and many
sponsors will not fund these overheads. Even when there
is the requisite equipment, there is the broader issue of
local constraints; unavailability of reagents in local mar-
kets, fuel shortages, lengthy and sustained power cuts
throughout the year, but particularly in the months leading
to the monsoon where power goes for up to 16 hours a
day; and difficulties in the transportation of equipment and
individuals (both because of the terrain, and the broader
infrastructural developments, like poorly maintained roads,
washed away in the monsoon). Poor Internet connections,
limited access to scientific journals, limited opportunities
for attendance at scientific conferences and debates due to
lack of financial resources as well as strict visa regulation
in the high income countries, all contribute to the exclu-
sion from access to the global circulation of resources.
While individual local researchers are high on demand to
work as consultants, and often oversubscribed with multi-
ple research engagements, many have successfully devel-
oped their capacity to move between different
organizations within or outside of the country or are poa-
ched by them. All these issues limit the capacity for sus-
tained development of institutional research capacity
within Nepal.
EMERGING REGULATORY AND ETHICAL
FIELD
We turn now to the regulation of this emergent field of
research practices. Prior to 1991, the Government of Nepal
monitored health related research through the Nepal Medi-
cal Research Committee based in the Ministry of Health,
which was established on 15 April 1982. Many externally
funded or sponsored research projects, often with Nepali
researchers working as junior research partners or consul-
tants, obtained research and ethical clearance from their
own review bodies in the Northern countries, not obtaining
permission from Nepal at all. What local reviews were
done up to this time was conducted under the chairman-
ship of the Secretary of Health. The sweeping political
changes that followed in the wake of the revolution in
1990 in Nepal leading to the reinstatement of democratic
process23 , also resulted in changes within state run institu-
tions. The NHRC was set up in 1991, by an act of parlia-
ment, with the mandate to, on the one hand, promote
research culture, and on the other, review, regulate and
approve research proposals in relation to health. Its budget
comes from the Ministry of Health. The building in which
the NHRC is housed sits behind the Ministry of Health,
and access is through the same main entrance way, where
visitors need to be signed in by police guards. The execu-
tive board of the NHRC is politically appointed. Seven of
them are nominated by the Cabinet and five are representa-
tives from different institutions including the Ministry of
Health and Population, the Ministry of Finance, the
National Planning Commission, Chief of the Research
© 2016 The Authors Developing World Bioethics Published by John Wiley & Sons Ltd
23 J. Whelpton. 2005. A History of Nepal. Cambridge: Cambridge Univer-
sity Press; M. Hofton, W. Raeper & J. Whelpton. 1999. People, Politics
and Ideology: Democracy and Social Change in Nepal, Kathmandu: Man-
dala Book Point.
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Committee of the Institute of Medicine and the Chairper-
son of the Nepal Medical Council. The executive chief of
the council can either be the chairperson or the member
secretary.
From 1991, review of health related research was car-
ried out through the Scientific and Ethics Committee at the
NHRC. In addition, further formalization of approach
resulted in the first National Guidelines for Ethical
Review, published in 1995; these were formally approved
by the Ethics Board of the NHRC in 2001; and the Ethical
Review Board (ERB) in its current form was established
in that same year. The Executive Committee of the NHRC
nominates the ERB. In June 2012 the constitution of the
ERB was as follows: eleven members in total, with a gen-
der balance of nine men to two women, and almost
entirely made up of biomedical doctors (n=9), reflecting
this particular disciplinary bias. Among these there were a
pediatrician, a public health specialist, obstetrician/ gyne-
cologist, surgeon, general physician, dental surgeon, Ayur-
vedic physician, lawyer, and a biostatistician. A team of
research officers in the research office manages the admin-
istration of applications and the review process.
Any new health related research conducted in Nepal has
to be submitted to the NHRC following the format avail-
able on their website.24 The parameters for what consti-
tutes research into health remain somewhat unclear,
however, with policy oriented and health systems research
not explicitly fitting into this category. For example,
researchers and managers of programmatic interventions
interviewed often had a question: does behavioral research
into Maternal and Child Health issues fall under the rubric
of development, or more medically defined bio-medical
health? While there has been an increase in the studies
seeking ethical approval, there is no uniform understanding
regarding what kind of research studies needs to get
NHRC ethical approval. Informants from a few institutions
maintained that only studies that have the component of
biological samples should take ethical approval although
the NHRC maintains that all research in the health sector,
regardless of their type, need to undergo their process of
ethical review. One research manager of a major research
organization told us that it is mandatory to take approval
for studies taking biological samples but they did not take
approval for behavioural studies.
Thus seeking ethical approval from the NHRC seems to
depend on the initiative and the understanding of the con-
cerned investigators. NHRC officials we interviewed main-
tain that there is large number of research activities taking
place within the framework of programmatic intervention
that are not always submitted for ethical review. Critics,
on the other hand, argued that NHRC interest on ethical
review of everything that is concerned with the generation
of evidence is primarily driven by its “rent seeking behav-
ior” in that it charges 3% of the total research budget for
research projects costing more than $10,000 and $100 for
those costing less than $10,000.
The basic guiding principles of review were presented
by the Coordinator of the ERB at the workshop on ethics
we convened as follows: That the proposed research is
essential; that human participation is voluntary; that
research on children is conducted only if there is a poten-
tial benefit to child’s welfare (and only with parental con-
sent, and the agreement of the child); that research on
pregnant women is performed only if it contributes to their
welfare; and that vulnerable groups are protected by appro-
priate mechanisms. He presented the basic bioethical prin-
ciples, of non-maleficence and beneficence; of the need for
appropriate compensation; that the researchers are compe-
tent; and that the distribution of both burden and benefits
for the research have been carefully thought through.
In addition, he stated the research also needs to address
the following: That mechanisms for dissemination of
research findings exist; that the research has good institu-
tional support; that mechanisms for maintaining the confi-
dentiality of data exist; that researchers, sponsors and
funding agencies accept the legal responsibility for the
research. The final guiding principles make up the list:
That conflict of interests are declared and are transparent;
that externally funded research should resonate with the
needs of Nepal; and that the transport of any biological
materials out of the country should only be for the purpose
stated in the original proposal. In order to facilitate the
work of the ERB, a Standard Operating Procedure (SOP)
has been developed. However, NHRC policy and regula-
tions neither define health systems research nor do they
have any provision on it.
Our research showed that over the years the review pro-
cess at the NHRC has improved significantly. It has a sys-
tem in place for carrying out reviews. After the study has
been reviewed by the internal reviewer of the council, it is
sent to an external reviewer. As of 2012, a reviewer was
paid a remuneration of Nepali Rupees 1,200 ($15). The
NHRC maintains a roster of experts for reviewing the
research proposals. There are certain checklists on rele-
vance, methods, variables etc. that are looked at while
reviewing the proposals. The comments or questions from
the reviewer are sent to the researchers and the responses
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from the researchers are sent back to the reviewer after
which the proposal, if deemed appropriate, is given
approval. Care is taken around conflict of interests when
assigning proposals to review.
There are varied perceptions regarding how the NHRC
functions. One of the major critiques of the organization is
the time taken. While some of the organizations maintain
that there has been a change in the scenario from the past
where the council used to take up to three months to
review a proposal, they feel that the NHRC still lacks the
capacity and human resources to undertake its activities in
a timely manner. An administrative officer at the NHRC
told us that they do not have enough human resources to
monitor studies. It uses a part of the application fee to sup-
port monitoring of research studies. Being dominated by
medical professionals, the NHRC also lacks capacity to
review the varied kinds of research proposal in the health
sector and thus draws on expertise of independent consul-
tants for reviews.
Given that the NHRC charges 3% of the total budget of
a research study for research projects costing more than
$10,000, as a fee to review the research proposal, there is
dissent amongst the local and international researchers
regarding this uncapped fee structure. Some research orga-
nizations feel that the fee should be capped or they end up
paying a huge amount of money for large research pro-
jects. In collaborative research projects, often there are no
allocated funds for this purpose, which could create prob-
lems to conduct the research projects in Nepal. This issue
of uncapped fee has remained unresolved.
Finally, the NHRC does not have the capacity to review
increasing number of applications all by itself. It has dele-
gated responsibility to other research oriented entities. In
particular, the increasing number of medical and nursing
schools and the research activities within these medical
educational institutions has led to the establishment of
institutional review committees (IRCs). As of 2012, 20
medical education institutions have been given approval to
run IRCs. Institutions are allowed to run their own IRCs,
but they should be established according to the guidelines
of the NHRC.25 These need to be approved by the ERB of
the NHRC, and report every six months on their activities.
The IRCs are allowed to review and approve studies that
are carried out by students as a part of their degree or
internally funded research. For research at national or
international levels, multi-sited research, externally funded
research and clinical trials, they have to seek approval
from the ERB itself. Apart from the guidelines, there is
very little understanding, however, on how these IRCs
function and review the proposals.
CONCLUDING REMARKS: NHRC POLICY
IN THE CONTEXT OF NEPAL’S
POLITICAL ECONOMY OF RESEARCH
What are the implications of this political economy of
health sector research on the formation of NHRC guideli-
nes, policy and practice? How are the emerging regulatory
and ethical fields taking into account these complexities?
First, the Nepal case shows that there is a tension
between a definition of what counts as health research and
therefore should be subjected to ethical review by the
NHRC, and what does not count as health research or
counts merely as quality improvement, monitoring and
evaluation exercises. While this is not unique to Nepal,
this becomes particularly important when most health
research activities in the country are organised as program-
matic interventions and in the form of studies examining
feasibility and efficacy of a particular model of service
delivery, monitoring and evaluation, programme reviews
and assessments etc. A first step, therefore, is to develop a
census of health research activities through mapping,
which could give a more accurate sense of the overall
research activities.
Second, due to limited resources and that the NHRC
board’s term is shaped by frequent changes in the govern-
ment, ethical review at the NHRC takes longer than
expected. There is not enough expertise available at
NHRC for different types of research. For short-term
research projects, there is not much time to get the review
process sorted, as this is not usually built in into the time-
line proposed by the sponsors. Moreover, the availability
of the ERB members could also be an issue, as the meet-
ing of the ERB needs to take place with the presence of at
least 6 out of 11 members, for the approval of the study.
Third, given that many research studies tend to have for-
eign investigators, the NHRC has made a mandatory pol-
icy that there should be a Nepali Co-Investigator (Co-I) in
the application. While NHRC policy is informed by an
approach to enhance local capacity, these enforced mecha-
nisms do not always lead to active participation of Co-Is,
who may be included mainly to meet the policy require-
ment rather than as genuine research collaborators leading
to enhancing research culture. Therefore, it might be useful
to think of a broader approach in terms of encouraging
Co-Is to have protected time for research as well as includ-
ing participation in research and publication as criteria for
their promotion and career progression.
Fourth, the nature of research collaborations has often
increased individual capacity at the expense of institutional
and organizational research capacity (as reflected in intra
organizational transfer of researchers, and poaching). The
unequal relationship between the sponsors and the sub-
contractors mean that sub-contractors have very little con-
trol over both the overall design and what happens to the
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research results once they are submitted. Although the
local research organizations as sub-contractors end up
doing most of the work on the ground, they rarely received
direct funding from sponsors. There is very little resources
available to meet indirect costs for carrying out research
activities. This has implications for the limited ownership
of data, and indirect sub-contracted budgets allows for lit-
tle or no protected time to work on research publications.
Fifth, responsibility for the publication of research
results remains unclear. Results are either published in
international journals–where there is now frequently provi-
sion for cheaper open access if there are low-income coun-
try authors–or are unknown, and unpublished. A provision
of the terms for permission to undertake research could be
insistence on publication in Nepalese journals in addition
to open-access international journals and other publication
outlets.
In conclusion, one of the key challenges in global health
is the lack of research capacity in low and middle-income
countries. The Director General of the WHO suggested in
1998 that improving health and reducing poverty in devel-
oping countries requires a quantum leap in capacity build-
ing’.26 There has been a perceived change in the position
of Nepali research institutions, which previously mainly
worked to implement pre-designed research and acted as
data couriers to Northern partners. Despite many now
being involved as research partners, there is very little evi-
dence that such a shift is changing the rules of the game.
The unequal field in which contract research and interna-
tional research collaboration takes place in low-income
countries raises questions that need to be answered from a
broader perspective than that which can be addressed from
within the ethics board. Moreover, an increasing number
of research activities in low-income countries that are
organized around experimental programmatic interventions.
These are often sponsored and conducted by international
collaborative assemblages of aid agencies, policy makers,
NGOs and research organisations. Their direct influence in
shaping policies and programmes calls for greater public
accountability and a broader definition of what constitutes
the ethics of health and development interventions.
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